cml

Showing NaN - NaN of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CML, Imatinib Trial in Seoul (high-dose imatinib)

Completed
  • CML
  • Imatinib
  • high-dose imatinib
  • Seoul, Korea, Republic of
    Novartis Investigational Site
Mar 9, 2021

CML, Nilotinib, Imatinib Resistant Trial in Seoul (nilotinib)

Completed
  • CML
  • +3 more
  • Seoul, Korea, Republic of
    St. Mary hospital, Catholic medical center
Feb 24, 2017

AML, MDS, ALL Trial in Seoul (fludarabine phosphate, busulfan)

Unknown status
  • AML
  • +4 more
  • fludarabine phosphate, busulfan
  • Seoul, Korea, Republic of
    Dong Hwan Kim
Dec 29, 2008